Evidence map›Paper›PMID 32206002›Full record

ArticleWorld journal of gastroenterology2020

Magnetic resonance imaging biomarkers for pulsed focused ultrasound treatment of pancreatic ductal adenocarcinoma.

Ezekiel Maloney, Yak-Nam Wang, Ravneet Vohra, Helena Son, Stella Whang, Tatiana Khokhlova, Joshua Park, Kayla Gravelle, Stephanie Totten, Joo Ha Hwang and 1 more

Open access · hybridAbstract read
In one paragraph

Article in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review of Robot-Assisted HIFU Therapy.Sensors (Basel, Switzerland) · 2023
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Ezekiel MaloneyDepartment of Radiology, University of Washington, Seattle, WA 98195, United States.
Yak-Nam WangApplied Physics Laboratory, University of Washington, Seattle, WA 98195, United States.
Ravneet VohraDepartment of Radiology, University of Washington, Seattle, WA 98195, United States.
Helena SonDivision of Gastroenterology, University of Washington, Seattle 98195, WA, United States.
Stella WhangDivision of Gastroenterology, University of Washington, Seattle 98195, WA, United States.
Tatiana KhokhlovaDivision of Gastroenterology, University of Washington, Seattle 98195, WA, United States.
Joshua ParkDepartment of Radiology, University of Washington, Seattle, WA 98195, United States.
Kayla GravelleDivision of Gastroenterology, University of Washington, Seattle 98195, WA, United States.
Stephanie TottenDivision of Gastroenterology, University of Washington, Seattle 98195, WA, United States.
Joo Ha HwangDivision of Gastroenterology & Hepatology, Stanford University School of Medicine, Redwood City, CA 94063, United States.
Donghoon LeeDepartment of Radiology, University of Washington, Seattle, WA 98195, United States. dhoonlee@uw.edu.
University of Washington · USUniversity of Washington Applied Physics Laboratory · US

Funding

Ultrasound enhanced penetration for treatment of pancreatic cancerR01CA154451 · NCI · UNIVERSITY OF WASHINGTON · PI HWANG, JOO HA · 2011 to 2021
$4.3M
MR-HIFU induced drug delivery for pancreatic cancer treatmentR01CA188654 · NCI · UNIVERSITY OF WASHINGTON · PI LEE, DONGHOON · 2015 to 2019
$2.6M
NCI NIH HHS R01 CA154451NCI NIH HHS R01 CA188654
6 · The paper itself

Abstract

backgroundThe robust fibroinflammatory stroma characteristic of pancreatic ductal adenocarcinoma (PDA) impedes effective drug delivery. Pulsed focused ultrasound (pFUS) can disrupt this stroma and has improved survival in an early clinical trial. Non-invasive methods to characterize pFUS treatment effects are desirable for advancement of this promising treatment modality in larger clinical trials.

aimTo identify promising, non-invasive pre-clinical imaging methods to characterize acute pFUS treatment effects for

methodsWe utilized quantitative magnetic resonance imaging methods at 14 tesla in three mouse models of PDA (subcutaneous, orthotopic and transgenic -

resultsMean high-

conclusionT2, glycosaminoglycan CEST, and ADC maps may provide reliable quantitation of acute pFUS treatment effects for patients with PDA.

Indexed as

Magnetic Resonance ImagingAnimalsBiomarkersCarcinoma, Pancreatic DuctalDrug Delivery SystemsInflammationMicePancreatic NeoplasmsPoint MutationSoftwareUltrasonic TherapyBiomarkersFocused ultrasoundMultiparametric magnetic resonance imagingPancreatic adenocarcinoma

Identifiers

PMID32206002
PMCPMC7081013
OpenAlexW3009376537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.